Establishment of an Embryo Implantation Model In Vitro
June 21st, 2024
This protocol describes methodologies to establish simple and efficient embryo implantation in vitro model for evaluating the relevant molecules affecting the embryo implantation process.
Embryo implantation. The initial step of a successful pregnancy is crucial for understanding its biological basis and addressing the challenges of infertility. The aim of this study is to establish a consistent platform for analyzing embryo-endometrium interactions under controlled conditions.
Based on this in vitro model, we found that ultra-high concentrations of estrogen significantly reduce the embryo implantation rates, whereas progesterone supplementation could dose-dependently alleviate these negative effects. This study offers new insights and therapeutic strategies for improving pregnancy rates in fresh embryo transfer during controlled ovarian stimulation for IVF. Compared to a three-dimensional culture system, this in vitro model offers a simple, rapid, and cost-effective platform that can be established in most laboratories and exhibits high reproducibility and reliability, making it an advantageous tool for research and development in the field of reproductive biology.
To begin, obtain a six to eight-week-old female mouse and inject the PMSG followed by HCG at a 42 to 48-hour interval. Mate the female mouse with a male of comparable age. After euthanizing the female mouse, open the abdomen and locate its genitalia.
Using forceps, stretch the oviduct, ovary, and fat pads. With scissors, cut the oviduct and ovary, followed by the uterus. Transfer the obtained oviduct to a 35-millimeter Petri dish prefilled with M2 medium.
Puncture the enlarged ampulla of the oviduct to release or pinch the cumulus zygote complex. Using forceps, transfer the complex to M2 solution containing 0.5 milligrams per milliliter of hyaluronidase and incubate for several minutes. With an egg transfer pipette, collect the zygotes and wash them in M2 medium containing BSA to remove residual hyaluronidase, cumulus cells, and impurities.
To begin, obtain embryos from freshly mated female mouse. Prepare 12 micro droplets of potassium simplex optimized medium at the bottom of a 35-millimeter Petri dish. Cover the microdroplets with three to five milliliters of mineral oil and place the Petri dishes in an incubator at 37 degrees Celsius with 5%carbon dioxide for equilibration.
Using a transfer pipette, transfer the mouse embryos from M2 medium to KSOM medium. Place the washed embryos in the prepared KSOM microdroplets and incubate them at 37 degrees Celsius with 5%carbon dioxide for four days. Select advantageous blastocysts according to their size, inner cell mass, number of trophoblast cells, and degree of expansion.
Add one milliliter of 2%gelatin to a 12-well culture plate and incubate at 37 degrees Celsius for 30 minutes. Then aspirate the excess gelatin and let the bottom of the plate dry completely. Seed human endometrial adenocarcinoma cells or Ishikawa cells into the gelatin-coated 12-well plate and incubate the plate for 24 hours.
Gently place 5 to 15 fresh blastocysts into each well of the 12-well plate containing the cells. After 48 hours, observe the embryos under a microscope to assess their attachment status after moving the plate three times. Unattached embryos will float or roll over the surface of cells.
Finally, calculate the embryo implantation rate in the presence of various estrogen concentrations. The results demonstrated that near physiological concentrations of 17 beta-estradiol increased embryo implantation rates compared to the control without 17 beta-estradiol. However, ultra-high concentrations of 17 beta-estradiol around 100 nanomolar significantly reduced embryo implantation rates.
Overview
This study focuses on establishing an in vitro model to analyze embryo implantation, a critical process for successful pregnancy. The findings indicate that high concentrations of estrogen negatively affect embryo implantation rates, while progesterone can mitigate these effects, providing new insights for improving IVF outcomes.
Key Study Components
Research Area
- Reproductive biology
- Embryo-endometrium interactions
- Infertility treatments
Background
- Embryo implantation is essential for pregnancy success.
- The study aims to address infertility challenges.
- Controlled conditions are necessary for studying implantation mechanisms.
Methods Used
- In vitro embryo implantation model
- Mouse embryos and endometrial cell lines
- Culture techniques and hormonal treatments
Main Results
- Ultra-high estrogen concentrations decrease implantation rates.
- Progesterone positively influences implantation in a dose-dependent manner.
- The model provides a reliable platform for future reproductive studies.
Conclusions
- This research highlights hormonal impacts on embryo implantation.
- Results suggest therapeutic strategies for enhancing pregnancy rates in IVF.
Frequently Asked Questions
Executive Industry Relevance
Establishing a robust in vitro embryo implantation model addresses a critical bottleneck in reproductive biology and early-stage drug discovery. This platform enables controlled interrogation of embryo-endometrium interactions, supporting predictive confidence in molecule screening and mechanistic de-risking for fertility-related targets. Its reproducibility and scalability position it as a valuable asset for portfolio triage and translational research in reproductive health.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables systematic evaluation of molecular regulators of embryo adhesion and endometrial receptivity.
- Supports functional target validation by quantifying the impact of hormones and candidate molecules on implantation rates.
- Facilitates mechanistic de-risking by isolating specific pathway effects in a controlled environment.
Screening & Assay Development
- Provides a standardized, reproducible co-culture system for high-confidence screening of cytokines, drugs, and transcription factors.
- Delivers quantitative adhesion rate outputs to benchmark compound efficacy and optimize assay conditions.
- Enables rapid, scalable preparation of validated biological systems for downstream screening workflows.
Translational & Preclinical Research
- Aligns with disease-relevant models for infertility and endometrial dysfunction studies.
- Supports translational biomarker identification by linking molecular interventions to functional implantation outcomes.
- Facilitates continuity from discovery through preclinical validation of reproductive therapeutics.
Pipeline & Workflow Integration
This in vitro model bridges early discovery and preclinical research by enabling hypothesis-driven testing of embryo-endometrium interactions and candidate interventions.
- Discovery Biology: Supports hypothesis testing on hormonal and molecular modulators of implantation.
- Screening: Provides reproducible, quantitative readouts for compound evaluation and assay optimization.
- Analytics: Enables statistical comparison of adhesion rates across experimental conditions and molecule concentrations.
- Translational Research: Connects in vitro findings to preclinical models of reproductive health and infertility.
- Enterprise Reuse: Offers a cost-effective, scalable platform adaptable across research teams and therapeutic programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target validation and mechanistic studies of implantation.
- Operational Value: Delivers standardized, reproducible, and rapid assay workflows suitable for broad adoption.
- Strategic Value: Improves go/no-go decision-making and reduces late-stage biological risk in reproductive health portfolios.
- Portfolio Impact: Enables risk-adjusted prioritization of candidate molecules and therapeutic strategies.
Implementation Considerations
- Requires expertise in embryo handling, cell culture, and quantitative assay analysis.
- Needs access to standard cell culture infrastructure and microscopy for adhesion assessment.
- Demands cross-team standardization of embryo selection and co-culture protocols for reproducibility.
- Adaptable to various model systems but may require optimization for species or cell line differences.
- Limitations include reliance on in vitro conditions that may not fully recapitulate in vivo implantation dynamics.
